AbbVie

Tweet this page
<
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 14 Mar 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

1,000,000€ - 1,249,999€

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

2.4 Fte (8)

Lobbyists with EP accreditation

2

High-level Commission meetings

6

Lobbying Costs over the years

  • Info

    AbbVie   (ABBV)

    EU Transparency Register

    934069612666-51 First registered on 20 Jan 2014

    Goals / Remit

    AbbVie is a Specialty-focused, research-based biopharmaceutical company focused on developing new products and new ways to help people manage some of the most serious health conditions. We are scientists, researchers, communicators, manufacturing specialists, and regulatory experts.

    AbbVie began as the pharmaceutical leader, Abbott, which was founded in 1888 by Chicago physician, Dr. Wallace Abbott. Since then, Abbott has evolved to become a global healthcare leader, delivering innovative pharmaceutical, nutritional, diagnostic, and medical products to people in more than 150 countries.

    On January 1, 2013, AbbVie was founded, a global biopharmaceutical company with the focus and capabilities to address some of the world's greatest health challenges. AbbVie has the stability, resources, expertise, and passion to discover, develop, and bring to market groundbreaking science to solve the biggest health problems that face the world today (...)

    Main EU files targeted

    - Pharmaceutical Strategy, and in particular review of the basic pharmaceutical legislation, of the Orphan Medicinal Products Regulation, and of the Paediatric Medicines Regulation
    - European Health Data Space
    - Industrial Policies and IP Action Plan, and in particular questions around patents, SPC and so on.
    - Joint Procurement for medical countermeasures
    - Competition in the pharmaceutical sector
    - Revision of Medical Device and IVD Regulation
    - Urban Waste water Directive
    - Packaging and Packaging waste
    - European Commission activities around ensuring effective, resilient and sustainable healthcare systems
    - Access to Medicines
    - Beating cancer plan

    Address

    Head Office
    North Waukegan Road, 1
    North Chicago IL 60064
    UNITED STATES
    EU Office
    Square de Meeus 37
    Brussels
    BELGIUM

    Website

  • People

    Total lobbyists declared

    8

    Employment timeLobbyists
    75%2
    25%2
    10%4

    Lobbyists (Full time equivalent)

    2.4

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    2 accreditations were / are live (in bold) for the selected state of 22 Jun 2024

    Name Start date End Date
    Philip SCHWAB 07 Jun 2023 07 Jun 2024
    Christian BARACAT 22 Sep 2023 20 Sep 2024
    Janusz LINKOWSKI 20 Mar 2024 02 Oct 2024
    Felix KUBITSCHEK 22 Sep 2023 01 Feb 2024
    Felix KUBITSCHEK 12 Jul 2022 12 Jul 2023
    Christian BARACAT 25 Jun 2022 24 Jun 2023
    Ms Jennifer SHUM 05 Feb 2016 02 Feb 2017

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    - American Chamber of Commerce to the EU
    - European Federation of Pharmaceutical Industries and Association (EFPIA)
    - EuropaBio – the European Association of Bio-Industries
    - Friends of Europe

    Member organisations

    - ACHIEVE coalition (Associations collaborating on Hepatitis to Immunize and Eliminate the Viruses in Europe), which has a secretariat that is run by FIPRA

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2023 - Dec 2023

    Lobbying costs for closed financial year

    1,000,000€ - 1,249,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    NameAmount
    grayling 25,000€ - 49,999€
    fipra, support for the achieve coalition 50,000€ - 99,999€
    rpp group 100,000€ - 199,999€

    Intermediaries for current year

    Name
    fti consulting
    rpp group

    Closed year Costs

    1,000,000€ - 1,249,999€

    Other financial info

    Since 2022 and the new interinstitutonal agreement and the guidelines issued in that context, the reporting structure has changed. This led to adding additional employees and their salaries whose activities are now considered in-scope, as well as to counting the membership fees to organization we are members of (which we previously excluded to avoid double reporting).

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    AbbVie has supported a number of roundtables that were hosted by members of the European Parliament and politicla parties, and has also participated in the EU public debate through op-eds that were published in the relevant trade press.

    Other activities

    None declared

  • Meetings

    Meetings

    6 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

Download this datacard